Literature DB >> 1831062

Association of amyloid P component with complement proteins in neurologically diseased brain tissue.

H Akiyama1, T Yamada, T Kawamata, P L McGeer.   

Abstract

Amyloid P component (AP) was detected in a number of lesions in human brain associated with chronic degenerative disease. These lesions included diffuse and consolidated amyloid deposits, cerebral amyloid angiopathy, neurofibrillary tangles, neuropil threads and complement activated oligodendroglia. The staining for AP generally paralleled that for complement proteins C4d and C3d, suggesting that AP may serve as an adjuvant for phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831062     DOI: 10.1016/0006-8993(91)91148-t

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

Review 1.  Roles of the complement system in human neurodegenerative disorders: pro-inflammatory and tissue remodeling activities.

Authors:  Philippe Gasque; Jim W Neal; Sim K Singhrao; Eamon P McGreal; Yann D Dean; Beek Johan Van; B Paul Morgan
Journal:  Mol Neurobiol       Date:  2002-02       Impact factor: 5.590

Review 2.  Local neuroinflammation and the progression of Alzheimer's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease.

Authors:  S E Stoltzner; T J Grenfell; C Mori; K E Wisniewski; T M Wisniewski; D J Selkoe; C A Lemere
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

4.  A quantitative proteomic approach to prion disease biomarker research: delving into the glycoproteome.

Authors:  Xin Wei; Allen Herbst; Di Ma; Judd Aiken; Lingjun Li
Journal:  J Proteome Res       Date:  2011-04-25       Impact factor: 4.466

5.  Up-regulated production and activation of the complement system in Alzheimer's disease brain.

Authors:  K Yasojima; C Schwab; E G McGeer; P L McGeer
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

6.  Lactotransferrin immunocytochemistry in Alzheimer and normal human brain.

Authors:  T Kawamata; I Tooyama; T Yamada; D G Walker; P L McGeer
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

7.  Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons.

Authors:  O Yasuhara; A Matsuo; I Tooyama; H Kimura; E G McGeer; P L McGeer
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.

Authors:  G A Tennent; L B Lovat; M B Pepys
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Amyloid-P-component-like immunoreactivity in beta/A4-immunoreactive deposits in Alzheimer-type dementia brains.

Authors:  M Kimura; H Arai; T Takahashi; N Iwamoto
Journal:  J Neurol       Date:  1994-01       Impact factor: 4.849

10.  Implication of complement system and its regulators in Alzheimer's disease.

Authors:  Martin V Kolev; Marieta M Ruseva; Claire L Harris; B Paul Morgan; Rossen M Donev
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.